Source: Journal of Clinical Pharmacy and Therapeutics. Unidade: FCF
Subjects: ESQUIZOFRENIA, REVISÃO SISTEMÁTICA
ABNT
HENRIQUE, Iara Carolina Barbosa et al. Economic evaluations on the use of aripiprazole for patients with schizophrenia: a systematic review. Journal of Clinical Pharmacy and Therapeutics, v. 45, n. 1, p. 1–15, 2020Tradução . . Disponível em: https://doi.org/10.1111/jcpt.13034. Acesso em: 17 out. 2024.APA
Henrique, I. C. B., Lima, T. de M., Melo, D. O. de, & Aguiar, P. M. (2020). Economic evaluations on the use of aripiprazole for patients with schizophrenia: a systematic review. Journal of Clinical Pharmacy and Therapeutics, 45( 1), 1–15. doi:10.1111/jcpt.13034NLM
Henrique ICB, Lima T de M, Melo DO de, Aguiar PM. Economic evaluations on the use of aripiprazole for patients with schizophrenia: a systematic review [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2020 ; 45( 1): 1–15.[citado 2024 out. 17 ] Available from: https://doi.org/10.1111/jcpt.13034Vancouver
Henrique ICB, Lima T de M, Melo DO de, Aguiar PM. Economic evaluations on the use of aripiprazole for patients with schizophrenia: a systematic review [Internet]. Journal of Clinical Pharmacy and Therapeutics. 2020 ; 45( 1): 1–15.[citado 2024 out. 17 ] Available from: https://doi.org/10.1111/jcpt.13034